TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis
Gilead and Galapagos Announce Tortuga Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint
pharmaceutical investing BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine
Rio Silver Provides Corporate Update as the Company Advances Toward High-Grade Silver Development in Peru
Surface Metals Inc. Confirms Open Mineralization and Expansion Potential at Cimarron Gold Project, Nevada
SAGA Metals Completes First Cross Section Through Extensive Oxide Layer in Trapper Zone at Radar Project in Labrador
